First Time Loading...

F-Star Therapeutics Inc
NASDAQ:FSTX

Watchlist Manager
F-Star Therapeutics Inc Logo
F-Star Therapeutics Inc
NASDAQ:FSTX
Watchlist
Price: 7.12 USD Market Closed
Updated: May 16, 2024

F-Star Therapeutics Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

F-Star Therapeutics Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
F-Star Therapeutics Inc
NASDAQ:FSTX
Selling, General & Administrative
-$23.1m
CAGR 3-Years
-38%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$12.7B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.7B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
-23%

See Also

What is F-Star Therapeutics Inc's Selling, General & Administrative?
Selling, General & Administrative
-23.1m USD

Based on the financial report for Dec 31, 2021, F-Star Therapeutics Inc's Selling, General & Administrative amounts to -23.1m USD.

What is F-Star Therapeutics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-32%

Over the last year, the Selling, General & Administrative growth was -19%. The average annual Selling, General & Administrative growth rates for F-Star Therapeutics Inc have been -38% over the past three years , -32% over the past five years .